title: Effect of home-based telemonitoring using mobile phone technology on the outcome of heart failure patients after an episode of acute decompensation: randomized controlled trial.
abstract: BACKGROUND
  Telemonitoring of patients with chronic heart failure (CHF) is an emerging concept to detect early warning signs of impending acute decompensation in order to prevent hospitalization.
  
  
  OBJECTIVE
  The goal of the MOBIle TELemonitoring in Heart Failure Patients Study (MOBITEL) was to evaluate the impact of home-based telemonitoring using Internet and mobile phone technology on the outcome of heart failure patients after an episode of acute decompensation.
  
  
  METHODS
  Patients were randomly allocated to pharmacological treatment (control group) or to pharmacological treatment with telemedical surveillance for 6 months (tele group). Patients randomized into the tele group were equipped with mobile phone-based patient terminals for data acquisition and data transmission to the monitoring center. Study physicians had continuous access to the data via a secure Web portal. If transmitted values went outside individually adjustable borders, study physicians were sent an email alert. Primary endpoint was hospitalization for worsening CHF or death from cardiovascular cause.
  
  
  RESULTS
  The study was stopped after randomization of 120 patients (85 male, 35 female); median age was 66 years (IQR 62-72). The control group comprised 54 patients (39 male, 15 female) with a median age of 67 years (IQR 61-72), and the tele group included 54 patients (40 male, 14 female) with a median age of 65 years (IQR 62-72). There was no significant difference between groups with regard to baseline characteristics. Twelve tele group patients were unable to begin data transmission due to the inability of these patients to properly operate the mobile phone ("never beginners"). Four patients did not finish the study due to personal reasons. Intention-to-treat analysis at study end indicated that 18 control group patients (33%) reached the primary endpoint (1 death, 17 hospitalizations), compared with 11 tele group patients (17%, 0 deaths, 11 hospitalizations; relative risk reduction 50%, 95% CI 3-74%, P = .06). Per-protocol analysis revealed that 15% of tele group patients (0 deaths, 8 hospitalizations) reached the primary endpoint (relative risk reduction 54%, 95% CI 7-79%, P= .04). NYHA class improved by one class in tele group patients only (P< .001). Tele group patients who were hospitalized for worsening heart failure during the study had a significantly shorter length of stay (median 6.5 days, IQR 5.5-8.3) compared with control group patients (median 10.0 days, IQR 7.0-13.0; P= .04). The event rate of never beginners was not higher than the event rate of control group patients.
  
  
  CONCLUSIONS
  Telemonitoring using mobile phones as patient terminals has the potential to reduce frequency and duration of heart failure hospitalizations. Providing elderly patients with an adequate user interface for daily data acquisition remains a challenging component of such a concept.
authors.affiliation: Department of Cardiology, Medical University Graz, Graz, Austria. friedrich.fruhwald@medunigraz.at
authors.forename: Daniel
authors.initials: D
authors.lastname: Scherr
authors.forename: Peter
authors.initials: P
authors.lastname: Kastner
authors.forename: Alexander
authors.initials: A
authors.lastname: Kollmann
authors.forename: Andreas
authors.initials: A
authors.lastname: Hallas
authors.forename: Johann
authors.initials: J
authors.lastname: Auer
authors.forename: Heinz
authors.initials: H
authors.lastname: Krappinger
authors.forename: Herwig
authors.initials: H
authors.lastname: Schuchlenz
authors.forename: Gerhard
authors.initials: G
authors.lastname: Stark
authors.forename: Wilhelm
authors.initials: W
authors.lastname: Grander
authors.forename: Gabriele
authors.initials: G
authors.lastname: Jakl
authors.forename: Guenter
authors.initials: G
authors.lastname: Schreier
authors.forename: Friedrich M
authors.initials: FM
authors.lastname: Fruhwald
mesh_terms: D000208:Acute Disease; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001794:Blood Pressure; D001835:Body Weight; D040421:Cell Phone; D034742:Electronic Mail; D005260:Female; D005500:Follow-Up Studies; D006333:Heart Failure / Q000188:drug therapy / Q000534:rehabilitation / Q000628:therapy*; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic / Q000379:methods; D018579:Patient Selection; D010820:Physicians; D011369:Professional-Patient Relations; D017216:Telemedicine / Q000379:methods*; D013686:Telemetry / Q000379:methods*
chemical_list: D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors
references.citation: J Am Coll Cardiol. 1999 Mar;33(3):734-42
references.pmid: 10080475
references.citation: J Telemed Telecare. 2004;10(2):113-7
references.pmid: 15068649
references.citation: Cardiology. 2008;111(2):134-9
references.pmid: 18376125
references.citation: Am Heart J. 2003 Oct;146(4):705-12
references.pmid: 14564327
references.citation: Stud Health Technol Inform. 2007;129(Pt 1):112-6
references.pmid: 17911689
references.citation: J Telemed Telecare. 2006;12(5):255-61
references.pmid: 16848939
references.citation: J Med Internet Res. 2005 Mar 26;7(1):e8
references.pmid: 15829480
references.citation: BMJ. 2007 May 5;334(7600):942
references.pmid: 17426062
references.citation: Circulation. 2007 Oct 2;116(14):1549-54
references.pmid: 17846286
references.citation: Circulation. 2007 Sep 25;116(13):1482-7
references.pmid: 17724259
references.citation: Arch Intern Med. 2008 Feb 11;168(3):316-24
references.pmid: 18268174
references.citation: Eur J Heart Fail. 2009 Mar;11(3):312-8
references.pmid: 19228800
references.citation: Eur J Heart Fail. 2007 Nov;9(11):1104-11
references.pmid: 17942364
references.citation: Eur J Heart Fail. 2001 Dec;3(6):723-30
references.pmid: 11738225
references.citation: Int J Cardiol. 2007 Sep 3;120(3):371-9
references.pmid: 17189654
references.citation: BMJ. 2005 Aug 20;331(7514):425
references.pmid: 16061499
references.citation: Am J Cardiol. 1999 Oct 1;84(7):860-2, A8
references.pmid: 10513789
references.citation: Int J Cardiol. 2009 Jan 9;131(2):192-9
references.pmid: 18222552
references.citation: J Am Coll Cardiol. 2005 May 17;45(10):1654-64
references.pmid: 15893183
references.citation: J Med Internet Res. 2004 May 14;6(2):e12
references.pmid: 15249261
references.citation: Eur Heart J. 2005 Jun;26(11):1115-40
references.pmid: 15901669
references.citation: J Am Coll Cardiol. 2005 Sep 20;46(6):1144-78
references.pmid: 16168305
references.citation: Eur J Heart Fail. 2009 Mar;11(3):319-25
references.pmid: 19174529
references.citation: Circulation. 2006 Dec 5;114(23):2466-73
references.pmid: 17116767